Promote a Clinical Trial


Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas

This research study is studying a chemotherapy as a possible treatment for Meningiomas (recurrent). The study intervention involved in this study is: --AZD2014 (vistusertib)

Sponsored by: Massachusetts General Hospital